Orthophar SRL
Orthophar reported total assets of 258,756 € at the end of the 2025 financial year (annual accounts filed with the NBB on 29 Jan 2026).
The score of Orthophar shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +2 % Total assets -2 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Orthophar's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 2,109 € | ||||
| Equity | 257,259 € | ||||
| Cash | 199,728 € | ||||
| EBITDA | 3,080 € | ||||
| Total assets | 258,756 € |
Filed annual accounts
- Year ended 29 Jun 2025filed on 29 Jan 2026
- Year ended 29 Jun 2024filed on 30 Jan 2025
- Year ended 29 Jun 2023filed on 29 Jan 2024
- Year ended 29 Jun 2022filed on 26 Jan 2023
- Year ended 29 Jun 2021filed on 27 Jan 2022
Orthophar's financial analysis
- Solvency99.4%sector median: 47.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Orthophar
Orthophar's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0879.711.212
- VAT number
- BE0879711212
- Peppol
- Registered · 0208:0879711212 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 02 Mar 2006
- Registered office
- 8510 Kortrijk
- Latest accounts
- 2025 · filed on 29 Jan 2026
- Activity
- Manufacture of medicaments (NACE 21201)
Orthophar (SRL) has been based in Kortrijk since 2006, active in: manufacture of medicaments. For 2025, it reports a net profit of 2,109 € and equity of 257,259 €; its revenue is not published. Its solvency stands at 99.4%, above the median of its sector (47.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Orthophar
Companies in the same business, of comparable size and area, outside its group.
- Dierenartsen Hond en Kat Manufacture of pharmaceutical preparations Deinze · balance sheet 321,318 €
- Apotheek Vandeperre Lut Retail sale of pharmaceutical products Meerhout · balance sheet 509,176 €
- Pharmacie des Pagodes Manufacture of basic pharmaceutical products Genappe · balance sheet 383,064 €
- Care4Excellence Manufacture of pharmaceutical preparations Overijse · balance sheet 307,250 €
- Nzosshealth Retail sale of pharmaceutical products Woluwe-Saint-Lambert · balance sheet 201,994 €
- B&S Services Wholesale of pharmaceutical and medical goods Hulshout · balance sheet 354,066 €
- CAWET Orthopédie Wholesale of pharmaceutical and medical goods Chimay · balance sheet 392,771 €
- Orthoservice Manufacture of medical and dental instruments and supplies Heist-op-den-Berg · balance sheet 146,341 €
Frequently asked questions about Orthophar
What is the revenue of Orthophar?
Orthophar files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Orthophar?
In Belgium, the VAT number is the company number prefixed with BE: BE0879711212 for Orthophar, if the company is VAT-registered. Its company number (CBE) is 0879.711.212.
Where is the registered office of Orthophar?
According to the CBE register, the registered office of Orthophar is in 8510 Kortrijk.
What is the equity of Orthophar?
At the close of the 2025 financial year, the equity of Orthophar amounts to 257,259 €, a solvency of 99.4% of total assets.
Who manages Orthophar?
The register lists 4 active mandates at Orthophar. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Orthophar
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →